Walsh E E
Department of Medicine, Rochester General Hospital, NY.
Vaccine. 1993;11(11):1135-8. doi: 10.1016/0264-410x(93)90075-9.
The protective efficacy of mucosal immunization with purified respiratory syncytial virus (RSV) fusion protein (F) using cholera toxin (CT) as an adjuvant was assessed in mice. Intranasal vaccination with F+CT induced F-specific serum IgG and nasal IgA and resulted in 75% protection from nasal virus replication compared with control mice. Intranasal CT+F with simultaneous parenteral F provided complete protection equivalent to intranasal live virus immunization.
在小鼠中评估了以霍乱毒素(CT)为佐剂,用纯化的呼吸道合胞病毒(RSV)融合蛋白(F)进行黏膜免疫的保护效果。用F+CT进行鼻内接种诱导产生了F特异性血清IgG和鼻内IgA,与对照小鼠相比,可使75%的小鼠免受鼻内病毒复制的影响。鼻内CT+F同时联合胃肠外给予F可提供与鼻内活病毒免疫相当的完全保护。